Get startedLog in
    Picture of Sartorius Stedim Biotech SA logo

    DIM — Sartorius Stedim Biotech SA Income Statement

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Sartorius Stedim Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    R2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,8873,4932,7762,7802,968
    Cost of Revenue
    Gross Profit1,5531,8351,2341,2071,345
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses2,0222,4982,3262,4202,446
    Operating Profit865995449360522
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes6471,130402219373
    Provision for Income Taxes
    Net Income After Taxes414880313179266
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income414876310175266
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income414876310175266
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS4.689.94.333.073.35
    Dividends per Share